Natixis Advisors
SWTX

Natixis Advisors’s SpringWorks Therapeutics SWTX Stock Holding History

Natixis Advisors’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,855
Closed -$782K – 1503
2022
Q1 		$782K Sell
13,855
-4
-0% -$229 ﹤0.01% 1185
2021
Q4 		$859K Sell
13,859
-756
-5% -$50K ﹤0.01% 1147
2021
Q3 		$927K Buy
14,615
+59
+0.4% +$4.55K ﹤0.01% 1107
2021
Q2 		$1.2M Buy
14,556
+2,404
+20% +$183K 0.01% 1056
2021
Q1 		$894K Buy
+12,152
New +$952K ﹤0.01% 1079

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return